Organizers claimed that nearly 2 million Hong Kong protesters took to the streets Sunday in a rally to demand the city's top official resign a day after she suspended — but...China Politicsread more
The Fed is not likely to make a move on interest rates when it meets next week, but it should clear the way for a rate cut later in the summer.Market Insiderread more
Software engineers straight out of college often make six-figure salaries, not counting equity compensation.Technologyread more
Representatives from the Chinese side say they think it likely that Chinese President Xi Jinping will attend the G-20 meeting later this month. But in order to reach a trade...China Economyread more
In the survey, 66% of Democratic primary voters say they'd be enthusiastic or comfortable about Biden as their nominee to take on President Trump in the 2020 election. Just...Politicsread more
You can save money by doing a quick check and unsubscribing from apps you no longer use.Technologyread more
Investors are holding out hope that Fed Chair Jerome Powell lays the groundwork for a rate cut as soon as July. Even just one this year would be a mistake, says Amanda Agati,...Trading Nationread more
A company spokesperson said the outage was the result of a "an internal technology issue" and was not security related.Retailread more
Mired in a crisis over its best-selling 737 Max plane, Boeing could hand the spotlight over to its rival Airbus at the Paris Air Show.Airlinesread more
Using MIT's living wage calculator, CNBC Make It mapped out the minimum amount a single parent must earn to meet their basic needs without relying on outside help in every...Earnread more
Luckin's opportunity in China is "one of the world's greatest retail growth opportunities," according to KeyBanc Capital Markets.Investingread more
Check out the companies making headlines after the bell:
Shares of Akcea Therapeutics and Ionis Pharmaceuticals plummeted more than 21 percent and nearly 15 percent, respectively, during after-hours trading after the two companies announced that they had received a complete response letter from the FDA regarding a new drug application for Waylivra. A complete response letter means that the FDA decided that it will not approve the drug in its current form.
Trading of the two stocks was halted for about an hour as a result of the news.
Shares of AMD rose more than 1 percent in the extended session. The chipmaker hit a twelve-year high earlier on Monday, extending a three-day rally as analysts have become more optimistic about the company's outlook.
Heico's stock is up more than 5 percent during after-hours trading after the aerospace and defense company released its third-quarter report. The company earned 49 cents per share for the quarter, 4 cents higher than analysts' estimates of 45 cents per share, according to Reuters. Heico also reported $465.8 million in sales, up from Wall Street estimates of $439.9 million.
Tiffany & Co. shares are down almost 1 percent in the extended session ahead of the company's earnings announcement on Tuesday before the bell. Wall Street expects the jewelry retailer to report revenues of $1.043 billion and earnings of $1.01 per share, according to Reuters.